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The Ca2+/calmodulin-dependent protein kinase II
(CaMKII) is critically required for the synaptic recruit-
ment of AMPA-type glutamate receptors (AMPARs)
during both development and plasticity. However,
the underlying mechanism is unknown. Using single-
particle tracking of AMPARs, we show that CaMKII
activation and postsynaptic translocation induce
the synaptic trapping of AMPARs diffusing in the
membrane. AMPAR immobilization requires both
phosphorylation of the auxiliary subunit Stargazin
and its binding to PDZ domain scaffolds. It does
not depend on the PDZ binding domain of GluA1
AMPAR subunit nor its phosphorylation at Ser831.
Finally, CaMKII-dependent AMPAR immobilization
regulates short-term plasticity. Thus, NMDA-depen-
dent Ca2+ influx in the post-synapse triggers a
CaMKII- and Stargazin-dependent decrease in
AMPAR diffusional exchange at synapses that con-
trols synaptic function.
INTRODUCTION
The development and plasticity of synapses involve the timely
recruitment of a plethora of proteins on both pre- and postsyn-
aptic sides through ill-defined mechanisms. At excitatory
synapses, two of the major proteins that are dynamically
recruited postsynaptically are the Ca2+/calmodulin-dependent
kinase II (CaMKII) and the AMPA-type glutamate receptor
(AMPAR). Numerous studies have shown that CaMKII is involved
in the activity and NMDA receptor (NMDAR)-dependent recruit-
ment of AMPARs both during synaptic development and
synaptic plasticity (Asrican et al., 2007; Hayashi et al., 2000;
Lee et al., 2009; Lisman et al., 2002; Merrill et al., 2005; Pettit
et al., 1994; Poncer et al., 2002; Rongo and Kaplan, 1999; San-
hueza et al., 2007; Zhang et al., 2008). However, it is unknown
how CaMKII increases the number of AMPARs at synapses.Two principal recruitment mechanisms can be anticipated:
CaMKII might promote the exocytosis of AMPAR-containing
vesicles and/or the trapping at the postsynaptic density (PSD)
of laterally diffusing AMPARs. While the evidence linking CaMKII
activation and AMPAR recruitment at synapses has been inter-
preted via the exocytosis mechanism (Maletic-Savatic et al.,
1998), the hypothesis that CaMKII can recruit AMPARs by diffu-
sional trapping has not been examined, even though a number of
findings indirectly support it (Lisman and Zhabotinsky, 2001).
First, NMDAR activation causes the rapid translocation of
CaMKII from dendritic compartments to activated synapses
(Hudmon et al., 2005; Shen and Meyer, 1999; Strack et al.,
1997). Second, following NMDAR activation, CaMKII can remain
at postsynaptic sites for prolonged periods of time, through
binding to several PSD proteins, including the NMDAR (Bayer
et al., 2006; Lisman et al., 2002; Otmakhov et al., 2004). Third,
CaMKII bound to the NMDAR remains active independent of
Ca2+/CaM (Bayer et al., 2001), which should allow it to phosphor-
ylate incoming membrane-bound proteins. Fourth, AMPARs are
highly mobile at the neuronal surface, rapidly switching between
extrasynaptic and synaptic sites (Bats et al., 2007; Borgdorff and
Choquet, 2002; Heine et al., 2008; Tardin et al., 2003). Fifth,
NMDAR stimulation, high-frequency stimulation, or increases
in intracellular Ca2+ (Borgdorff and Choquet, 2002; Heine et al.,
2008; Makino andMalinow, 2009; Petrini et al., 2009) all promote
the rapid immobilization of AMPARs. Taken together, these find-
ings suggest a scenario in which AMPARs are intrinsically mobile
at the neuronal surface and can be ‘‘trapped’’ at activated
synapses in a CaMKII-dependent manner.
In this study, we asses directly whether CaMKII activation and
postsynaptic translocation can recruit AMPARs at synapses by
trapping the freely diffusing receptors in the plasma membrane.
To this end, we either activated or inhibited CaMKII using
a number of genetic, pharmacological, and physiological
approaches while simultaneously tracking themobility of surface
AMPARs imaged via luminescent semiconductor quantum dots
(QDs) precoupled to specific antibodies against AMPAR
subunits (GluA1 or GluA2, corresponding to GluR1 and GluR2
[Collingridge et al., 2009]). Our results indicate that CaMKII acti-
vation stops the diffusion of surface AMPARs at synaptic sites.Neuron 67, 239–252, July 29, 2010 ª2010 Elsevier Inc. 239
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Figure 1. CaMKII Translocation Promotes
the Diffusional Trapping of AMPARs
(A) Sample images of a single spine containing
WT aCaMKII::GFP before and after activation of
NMDARs with glutamate/glycine (Glu/Gly). (Top
row) Diffuse aCaMKII::GFP fluorescence before
NMDAR activation (left) becomes clustered in
spine head 2–3 min after NMDAR activation (right).
(Middle row) Synaptic marker Homer::DsRed
before (left) and after (right) Glu/Gly. Note the
lack of redistribution of Homer::DsRed after treat-
ment. (Bottom row) Overlay of a QD-GluA1 trajec-
tory (30 s) before NMDAR activation (left) or after
aCaMKII::GFP translocation (right). Scale bar,
1mm.
(B) (Top) Diffusion over time plot for the trajectory
represented in (A). The first 30 s were sampled
before aCaMKII::GFP translocation; the last 30 s
after translocation. The arrow indicates Glu/Gly
application (2 min). (Bottom) Mean square dis-
placement (MSD) versus time plots for the pre-
and poststimulation periods. The MSD calculated
before stimulation is linear, which is characteristic
of free diffusion, whereas the MSD calculated after
stimulation exhibits a zero-flat curve typical of
immobile receptors.
(C) (Left) Single QD-GluA1 synaptic diffusion coef-
ficients decrease after NMDAR activation. (Right)
Median diffusion (±20%–75% IQR) of the data
from left (n = 9 QDs, paired t test, p < 0.05).
(D) (Left) Single QD-GluA1 diffusion coefficients
tend to increase at extrasynaptic sites after
NMDAR activation. (Right) Median diffusion of
the data from left (n = 14 QDs, paired t test, p =
0.095).
(E) (Left) Single QD-NCAM synaptic diffusion coef-
ficients increase after NMDAR activation. (Right)
Median diffusion of the data from left (n = 11 QDs,
paired t test, p < 0.05).
(F) (Left) Single QD-GluA1 synaptic diffusion coef-
ficients increase after NMDAR activation despite
aCaMKII::GFP K42R translocation. (Right) Median
diffusion of the data from left (n = 10 QDs, paired t
test, p = 0.005).
Neuron
Stargazin-Mediated AMPAR Immobilization by CaMKIIFurthermore, we show that this novel function of CaMKII is medi-
ated by phosphorylation of stargazin and binding of its C
terminus to PDZ domain scaffold proteins such as PSD95.
Finally, we show that this CaMKII-dependent trapping of
AMPARs to synaptic sites has a strong impact on paired-pulse
depression, a form of short-term plasticity strongly dependent
on the lateral mobility of AMPARs. Our experiments shine
new light into the dynamic interaction between two key compo-
nents of excitatory synapses and their fine tuning of synaptic
transmission.
RESULTS
Postsynaptic Translocation of CaMKII Promotes
the Diffusional Trapping of AMPARs at Synapses
Previous studies have shown that NMDAR activation triggers
a rapid translocation of CaMKII to synapses (Otmakhov et al.,
2004; Hudmon et al., 2005; Shen and Meyer, 1999; Strack240 Neuron 67, 239–252, July 29, 2010 ª2010 Elsevier Inc.et al., 1997). To directly examine whether CaMKII translocation
promotes the trapping of AMPARs, we tracked the lateral
mobility of individual AMPARs before and after CaMKII translo-
cation. Using fluorescencemicroscopy on cultured hippocampal
neurons and NMDAR stimulation with glutamate and glycine
(Glu/Gly), we simultaneously monitored (1) the translocation of
aCaMKII::GFP (2) and the surface mobility of AMPARs using
quantum dots precoupled to a GluA1 antibody (QD-GluA1)
(Richmond et al., 1996).
As previously shown, NMDAR activation promoted the rapid
translocation of aCaMKII::GFP to synaptic sites (marked by
Homer1C::DsRed) (Figure 1A). Concurrently, we observed that
the mobility of AMPARs, normally undergoing rapid exchange
between extrasynaptic and synaptic sites, was strongly reduced
at synapses with translocated aCaMKII::GFP (Figure 1C). In
most cases, AMPARs were completely immobilized during the
1 min posttranslocation recording period (Figure 1A). Mean
square displacement (MSD) versus time plots of AMPARs before
Neuron
Stargazin-Mediated AMPAR Immobilization by CaMKIItranslocation showed an almost linear relationship characteristic
of free diffusive molecules. In contrast, a flat MSD curve typical
of immobile receptors was observed after translocation (Fig-
ure 1B). AMPAR immobilization was only observed at synapses
where CaMKII translocated; they were not diffusionally trapped
either at extrasynaptic sites (Figure 1D) or synapses without
translocated CaMKII (Figure S1). We observed a similar
correlation for the mobility of GluA2 tagged with QDs through
a GluA2-specific antibody (data not shown, but see below).
To examine the specificity of this effect, we analyzed the
mobility of the neural cell adhesion molecule (NCAM) labeled
with QD precoupled to antibodies against NCAM (QD-NCAM).
Figure 1E shows no synaptic trapping of QD-NCAM after CaMKII
translocation.
While these results indicate a correlation between CaMKII
translocation and AMPAR immobilization at synaptic sites, they
do not reveal a causal relationship. To investigate whether
AMPAR immobilization was a direct consequence of CaMKII
postsynaptic translocation, we first overexpressed aCaM-
KII::GFP carrying a mutation (CaMKII::GFP I205K) that
suppresses its ability to translocate postsynaptically by disrupt-
ing its binding to the NMDAR (Bayer et al., 2001, 2006). The Glu/
Gly treatment promoted neither CaMKII::GFP I205K transloca-
tion nor synaptic immobilization of AMPARs (median diffusion
coefficient in mm2s1: before Glu/Gly 0.039; after 0.069; p =
0.124, n = 13).
Next, we investigated whether the catalytic activity of CaMKII
is required for the synaptic trapping of AMPARs. We overex-
pressed aCaMKII::GFP carrying a mutation known to disrupt
its kinase activity but not its ability to translocate to synapses
(CaMKII::GFP K42R) (Shen and Meyer, 1999; Yamagata et al.,
2009). Although the Glu/Gly treatment caused the synaptic
translocation of CaMKII::GFP K42R (data not shown), AMPARs
were not trapped at synapses enriched with this catalytically
inactive mutant (Figure 1F).
Altogether, these findings suggest that CaMKII translocation
promotes the diffusional trapping of AMPARs by the phosphor-
ylation of specific targets in the PSD.
Endogenous CaMKII Activation Triggers AMPAR
Surface Immobilization
We have previously observed that cultured hippocampal
neurons present spontaneous activity that drives a significant
fraction of CaMKII to postsynaptic sites via NMDAR activity
(Bayer et al., 2006) and reduces the mobility of AMPARs at
synapses (Ehlers et al., 2007). To determine whether basal
activity is sufficient to trigger AMPAR immobilization through
a CaMKII signaling cascade, we incubated neurons with the
membrane-permeable CaMKII peptide inhibitor CN21, derived
from the CaMKII natural inhibitor CaM-KIIN (amino acids
43–63) (Vest et al., 2007), and tracked AMPAR mobility (QD-
GluA2). We found that the basal mobility of AMPARs was
increased by the CaMKII inhibitory peptide (Figures 2A–2C) but
not by a scrambled version. To examine whether further activa-
tion of endogenous CaMKII can promote additional AMPAR
immobilization, we activated NMDARs with Glu/Gly and simulta-
neously tracked QD-labeled AMPARs. We found that indeed
NMDAR activation promoted a strong immobilization of synapticAMPARs (Figure 2D). More importantly, NMDAR activation had
no significant effect on synaptic AMPARmobility when delivered
in the presence of CN21 (Figure 2E).
To confirm these pharmacological studies, we used an shRNA
approach to downregulate endogenous aCaMKII. An shRNA
directed against an aCaMKII sequence that very effectively
downregulated the expression of aCaMKII subunit (but not
bCaMKII; Figure 2F) also triggered a significant increase in basal
AMPAR mobility (Figure 2G). Notably, further activation of
NMDARs had no effect on AMPAR mobility in shRNA-aCaM-
KII-transfected cells (Figure 2H). In contrast, NMDAR activation
promoted a strong immobilization of AMPARs in neurons trans-
fected with either a control shRNA (data not shown) or with
shRNA-aCaMKII plus a form of aCaMKII refractory to silencing
(Figure 2I).
We further investigated whether activation of NMDARs using
a different pharmacological protocol (‘‘chemical’’ LTP or cLTP)
also induces the diffusional trapping of AMPARs (Petrini et al.,
2009). We found that cLTP triggers the simultaneous immobiliza-
tion and accumulation of AMPARs at synapses. More impor-
tantly, both AMPAR immobilization and accumulation were
blocked when cLTP was induced in the presence of the CaMK
inhibitor KN93 (Figure S2).
Taken together, these results strongly suggest that activation
and postsynaptic translocation of CaMKII (whether endogenous
or recombinant) promote the diffusional trapping of AMPARs at
synapses.
High-Frequency Stimulation Promotes AMPAR
Immobilization through CaMKII Activation
We previously showed that high-frequency neuronal stimulation
(HFS; 50 Hz) induces a rapid NMDAR and Ca2+-dependent
AMPAR immobilization (Heine et al., 2008). We examined
whether this process depended on CaMKII activation by stimu-
lating a small population of neurons using a field bipolar elec-
trode (Figure 3D) in the absence or presence of KN93. We first
determined whether KN93 alone could increase basal AMPAR
mobility (QD-GluA2). Consistent with the results observed with
the peptide inhibitor CN21, application of KN93 increased the
basal mobility of AMPARs (Figures 3A–3C). More importantly,
KN93 also prevented the HFS-dependent immobilization of
AMPARs (Figures 3H and 3I). In contrast, HFS stimulation
induced a strong immobilization of AMPARs in neurons treated
with either the vehicle or the inactive analog KN92 (Figures
3E–3G). As a measure of CaMKII activation, we found that
HFS also promoted a strong synaptic translocation of CaMKII
(Figure S3). Thus, patterns of synaptic activity (spontaneous or
HFS-mediated) necessary for the activation of NMDARs and
CaMKII induced the immobilization of AMPARs.
Constitutively Active CaMKII Promotes a Strong
Immobilization of AMPARs
If CaMKII indeedmediates the immobilization of AMPARs at acti-
vated synapses, one might expect that a constitutively active
form of CaMKII (tCaMKII) could by itself immobilize AMPARs at
synapses. We thus tracked the mobility of endogenous GluA1-
containing AMPARs, 16–24 hr after transfection of tCaMKII::
GFP. We found that tCaMKII produced a strong reduction inNeuron 67, 239–252, July 29, 2010 ª2010 Elsevier Inc. 241
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Figure 2. Endogenous CaMKII Activation Triggers AMPAR Surface Immobilization
(A) Representative trajectories of QD-GluA2 membrane diffusion in control conditions or with the CaMKII inhibitory peptide CN21 (1 mM). Scale bar, 1 mm.
(B) Cumulative distribution of the diffusion coefficient of synaptic QD-GluA2 in neurons treated with vehicle (control), scrambled, or CN21 peptide.
(C) Median diffusion (±20%–75% IQR) of GluA2 in neurons treated with either vehicle (control, n = 881 QDs), scrambled (n = 530 QDs), or CN21 peptide
(n = 1451 QDs). Note that CN21 significantly increased the basal mobility of synaptic receptors (Wilcoxon rank sum test, p < 0.0005).
(D) (Left) Single QD-GluA2 synaptic diffusion coefficients decrease after Glu/Gly stimulation. (Right) Median diffusion of the data from left (n = 28 QDs, Wilcoxon
rank sum test, p < 0.05).
(E) (Left) CN21 blocks the NMDAR-dependent decrease in QD-GluA2 synaptic diffusion coefficient. (Right) Median diffusion of the data from left (n = 68 QDs,
Wilcoxon rank sum test, p = 0.30).
(F) shRNA knockdown of endogenous aCaMKII. (Left) Sample images of control- and aCaMKII-shRNA-transfected neurons (cotransfected with Homer::GFP).
Arrows point to transfected cells. Scale bar, 25 mm. (Right) Ratio of fluorescence intensity for aCaMKII or bCaMKII immunoreactivity between shRNA-transfected
and nearby nontransfected neurons. The shRNA directed against aCaMKII knocked down aCaMKII efficiently (10% of control, n = 34, p < 0.0005), with a small
effect on bCaMKII (80% of control, n = 17, p < 0.05).
(G) (Left) Cumulative distribution of the diffusion coefficient of QD-GluA2 in neurons treated with control (n = 145 QDs) or aCaMKII-shRNA (n = 164 QDs). (Right)
Knocking down aCaMKII levels increase the median diffusion of QD-GluA2.
(H and I) aCaMKII-shRNA prevents the NMDAR-dependent decrease in GluA1 mobility. (Left panels) Single QD-GluA1 synaptic diffusion coefficients before and
after Glu/Gly stimulation. (Right panels) Median diffusion of the data from left (n = 127 QDs, p < 0.05 [H], n = 57, p < 0.04 [I], Wilcoxon rank sum tests). Note that
aCaMKII knockdown blocks the NMDAR-dependent decrease of GluA1 synaptic diffusion coefficient (H), an effect rescued by the overexpression of an aCaMKII
mutant refractory to silencing (I). For these experiments, recombinant GluA1::SEP was tracked with anti-GFP labeled QDs (see Figure S2). Similar results were
obtained for endogenous GluA2 (data not shown).
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Figure 3. CaMKII Mediates the Activity-
Dependent Immobilization of AMPARs
(A) Overlay trajectories (red) of QD-GluA2 during
20 s and the synaptic marker Mitotracker (green)
in cultured neurons in the absence or presence
of the CaMK inhibitor KN93. Scale bar, 5 mm.
(B) KN93 increases the median diffusion (±20%–
75% IQR) of GluA2 in neurons treated with either
vehicle (ctrl, n = 195), KN92 (n = 86), or KN93
(n = 193). Wilcoxon rank sum test, p < 0.0005.
(C) Cumulative distribution of the diffusion coeffi-
cient of synaptic QD-GluA2 in neurons treated
with either vehicle (ctrl), KN92, or KN93.
(D) Schematic diagram representing the high-
frequency stimulation (HFS; 50 Hz) of neurons
using a bipolar electrode.
(E) Overlay trajectories (red) of QD-GluA2 during
60 s and the synaptic marker Homer1C::DsRed
before and after HFS. Note that the surface
explored by QD-GluA2 is dramatically decreased
after HFS. Scale bar, 5mm.
(F) The median diffusion (±20%–75% IQR) of
GluA2 is significantly decreased by HFS (control
n = 247 QDs, HFS n = 183 QDs; Mann-Whitney
test, ***p < 0.0001).
(G) Frequency distributions of the diffusion coeffi-
cients calculated from the trajectories of QD-
GluA2 shown in (F) before and after HFS in vehicle
and inactive analog KN92 (pooled data). Note
that HFS increased the immobile population
(Dinst.coeff. < 1 3 10
2 mm2/s).
(H and I) The CaMK inhibitor KN93 prevents the
HFS-dependent decrease in the median diffusion
(H) of GluA2 (ctrl n = 130 QDs, HFS n = 95 QDs;
Mann-Whitney test, p = 0.783) and the frequency
distributions (I) of their diffusion coefficients.
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Stargazin-Mediated AMPAR Immobilization by CaMKIIthe diffusion of both synaptic and extrasynaptic AMPARs
(Figures 4A–4C). Although it is unclear why AMPARs are immo-
bilized at extrasynaptic sites in presence of tCaMKII, it is likely
that scaffolding proteins present at extrasynaptic sites might
be mediating these effects (Figure S4; see below) (Aoki et al.,
2001). Though to a lesser extent, tCaMKII also promoted the
immobilization of AMPARs containing the GluA2 subunit (Figures
4D–4F). In contrast, tCaMKII overexpression had no effect on the
surface mobility of GABAA receptors (Figures S5A–S5D).
Because tCaMKII is a truncated, monomeric form of active
CaMKII, we verified whether the full-length, multimeric, and
constitutively active form of CaMKII (carrying a phosphomimetic
mutation at the autophosphorylation site Thr286; aCaMKII::GFP
T286D) could produce the same effect. We found that indeed
aCaMKII::GFP T286D promoted a strong immobilization of
AMPARs (QD-GluA1; Figures S5E–S5H).
Thus, bypassing NMDAR activation by directly overexpress-
ing a constitutively active form of CaMKII also leads to the diffu-
sional trapping of AMPARs. This strongly supports the notion
that CaMKII is a negative regulator of AMPAR lateral mobility.CaMKII Phosphorylation of AMPARs Is Not Necessary
for Immobilization
What is themechanism by which CaMKII causes the immobiliza-
tion of AMPARs? Since CaMKII phosphorylates GluA1 at Ser831
(Barria et al., 1997; Mammen et al., 1997), we first tested whether
this phosphorylation is necessary to modulate AMPAR mobility.
We cotransfected tCaMKII either with WT GluA1 or GluA1
S831A. To track exclusively the mobility of recombinant recep-
tors, we tagged the GluA1 subunit with an extracellular HA
epitope and used QDs precoupled to an antibody against HA
(QD-HA). We found that tCaMKII induced a significant immobili-
zation of HA-GluA1, although to a lesser extent than that
observed for endogenous GluA1-containing receptors (compare
Figures 4C and 5B).We found that tCaMKII equally promoted the
immobilization of HA-GluA1 S831A, suggesting that CaMKII
regulates AMPAR mobility by phosphorylating substrates other
than GluA1.
Another important CaMKII substrate is SAP97, a scaffolding
protein known to interact with GluA1 and to be recruited
to synapses upon phosphorylation (Mauceri et al., 2004). ToNeuron 67, 239–252, July 29, 2010 ª2010 Elsevier Inc. 243
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Figure 4. Overexpression of Constitutively Active CaMKII Promotes the Immobilization of AMPARsContaining theGluA1 andGluA2 Subunits
(A and B) (Top) Sample trajectories of GluA1-coupled QDs in untransfected (A) or tCaMKII::GFP-transfected neurons (B). Scale bar, 0.5 mm. (Bottom) Frequency
distributions of the diffusion coefficients calculated from such trajectories. Note that they are distributed in two populations: One with 1 3 102 < Dinst.coeff.
< 53 101 mm2/s (mobile receptors) and one with Dinst.coeff. < 13 10
2 mm2/s (slowly moving and immobile receptors falling in the immobile fraction). The fraction
of immobile receptors is dramatically increased in cells expressing tCaMKII::GFP compared to controls.
(C) (Top) Median diffusion (±20%–75% IQR) of QD-GluA1 at synaptic (left) and extrasynaptic sites (right). Note that tCaMKII::GFP overexpression significantly
decreased the diffusion of QD-GluA1 as compared to control untransfected neurons (control n = 680 QDs; tCaMKII n = 136 QDs; Mann-Whitney test: synaptic
p < 0.001, extrasynaptic p < 0.0001). (Bottom left) Mean (±SEM) proportion of immobile receptors. (Bottom right) Cumulative distribution of the diffusion coef-
ficient of QD-GluA1 (pooled synaptic and extrasynaptic) in untransfected and tCaMKII-transfected neurons.
(D–F) The distribution of GluA2 diffusion coefficient is similar to that of GluA1 (A-C), and tCaMKII overexpression also promoted a decrease in their median diffu-
sion (±20%–75% IQR) (control n = 354 QDs; tCaMKII n = 332 QDs; Mann-Whitney test: synaptic p < 0.05, extrasynaptic p < 0.0001) and an increase in their mean
immobile fraction (±SEM), when compared to untransfected controls (t test, p < 0.05). Scale bar, 0.5 mm.
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Stargazin-Mediated AMPAR Immobilization by CaMKIIexplore whether GluA1 binding to SAP97 was necessary for
AMPAR immobilization, we coexpressed tCaMKII with HA-
GluA1 lacking the PDZ-binding domain (HA-GluA1D7). We found
that HA-GluA1D7 mobility was still strongly reduced by tCaMKII
(median diffusion coefficient in mm2s1: HA-GluA1 0.1371 n =
157 QDs; HA-GluA1 D7 + tCaMKII 0.010 n = 307 QDs, p <
0.0001). These results suggest that the interaction between
GluA1 andSAP97 is not necessary for CaMKII-dependent immo-
bilization of AMPARs.
Stargazin Mediates the Effects of CaMKII
on AMPAR Mobility
Recent studies have identified members of the transmembrane
AMPAR regulatory proteins (TARP) family, such as Stargazin,
as important targets of CaMKII (Tomita et al., 2005b; Tsui and244 Neuron 67, 239–252, July 29, 2010 ª2010 Elsevier Inc.Malenka, 2006). Since we recently showed that Stargazin is
essential for the transient diffusional trapping of AMPARs at
synapses via interactions with PSD95 (Bats et al., 2007), we
examined the role of Stargazin and its phosphorylation in
mediating CaMKII-dependent immobilization of AMPARs. We
hypothesized that the implication of Stargazin could explain
why CaMKII promoted a weaker immobilization of recombinant,
as opposed to endogenous, AMPARs (Figure 4C versus 5B).
Overexpression of AMPARs alone might have favored the
expression of Stargazin-lacking AMPARs. To correct this possi-
ble bias and to try to enhance the immobilization-effect of
tCaMKII on recombinant AMPARs, we carried out triple transfec-
tions with HA-GluA1, tCaMKII, and WT Stargazin. Expression of
WT Stargazin increased the CaMKII-mediated immobilization of
recombinant HA-GluA1 to levels similar to those observed with
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Figure 5. CaMKII Immobilizes AMPARs through Stargazin
(A) Diagram representing the labeling strategy and targeted sites for manipulation on recombinant HA-GluA1 and Stargazin (STG). HA-GluA1 was tracked using
QD-coupled to HA antibodies.
(B) tCaMKII::GFP overexpression significantly decreased the median diffusion (±20%–75% IQR) of HA-GluA1 (GluA1 n = 68 QDs, GluA1+ tCaMKII n = 137 QDs,
Mann-Whitney test p < 0.001) as well as HA-GluA1 carrying a mutation at Ser831 (GluA1 S831A n = 131 QDs, Mann-Whitney test, p < 0.0001).
(C) Stargazin coexpression further decreased themediandiffusion ofHA-GluA1mediatedby tCaMKII::GFP (GluA1n=372QDs, STGn=246QDs,GluA1+ tCaMKII
n = 376 QDs, GluA1+ tCaMKII + STG n = 376 QDs, Mann-Whitney test, p < 0.0001).
(D) (Left) Diagram showing the labeling strategy of endogenous GluA1-containing AMPARs (with QDs coupled to GluA1 antibodies) accompanied with recombi-
nant forms of Stargazin. (Right) tCaMKII::GFP overexpression did not reduce the median diffusion of QD-GluA1 when coexpressed with Stargazin-mCherry
carrying mutations either at the CaMKII/PKC phosphorylation sites (control n = 136 QDs, tCaMKII + STG S9A n = 80 QDs; Mann-Whitney test, p < 0.05) nor
when lacking the PDZ-binding domain (Stargazin DC n = 202 QDs; Mann-Whitney test, p < 0.0001). In contrast, Stargazin phosphomimetic STG S9D triggered
GluA1 immobilization without tCaMKII::GFP (STG S9D n = 144, Mann-Whitney test, p < 0.0001).
(E) (Left) Diagram showing the labeling strategy of recombinant HA-Stargazin (tracked using QD-coupled to HA antibodies). (Right) tCaMKII::GFP overexpression
decreased the median diffusion of HA-STG but not HA-STG S9A (STG n = 313 QDs; STG + tCaMKII n = 223 QDs, Mann-Whitney test, p < 0.001; STG S9A +
tCaMKII n = 256 QDs, Mann-Whitney test, p > 0.05).
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Stargazin-Mediated AMPAR Immobilization by CaMKIIendogenous AMPARs (Figure 5C) and increased the immobile
fraction of AMPARs to significant levels. As previously reported
(Bats et al., 2007), we found that Stargazin itself had no effect
on AMPAR diffusion (Figure 5C). Also, we found that tCaMKII
had no effect on the mobility of recombinant GluA2 either in
the absence or presence of Stargazin (Figure S6) suggesting
a subunit-specific effect of CaMKII.
To investigate the possible implication of Stargazin phosphor-
ylation, we coexpressed tCaMKII with Stargazin Ser9Ala, a
mutated form of Stargazin carrying point mutations at the nine
putative CaMKII/PKC phosphorylation sites (Tomita et al.,
2005b). We tracked the mobility of endogenous AMPARs (QD-
GluA1) and found that tCaMKII was no longer able to immobilizethem. On the contrary, AMPAR mobility was significantly
increased when tCaMKII and Stargazin S9A were coexpressed
(Figure 5D). In addition, Stargazin S9A had no significant effect
on AMPAR mobility when expressed alone, though there was
a tendency to increase receptor mobility (data not shown).
To examine whether the interaction between Stargazin and
PDZ domain-containing proteins such as PSD95 was necessary
for the effects of tCaMKII, we coexpressed tCaMKII and Starga-
zin DC, a mutant lacking the PDZ binding site (last four residues
of the C terminus). We found that tCaMKII was again unable
to immobilize endogenous AMPARs (QD-GluA1) when coex-
pressed with Stargazin DC (even though the phosphorylation
sites were intact). As with Stargazin S9A, we found that AMPARNeuron 67, 239–252, July 29, 2010 ª2010 Elsevier Inc. 245
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Stargazin-Mediated AMPAR Immobilization by CaMKIImobility was significantly increased when tCaMKII and Stargazin
DCwere coexpressed (Figure 5D). To determinewhether Starga-
zin phosphorylation was sufficient to immobilize AMPARs, we
overexpressed a Stargazin phosphomimetic mutant (STG S9D)
alone and found that it promoted a strong immobilization of
AMPARs (Figure 5D).
Since our results suggest that CaMKII is directly stabilizing
Stargazin (and only indirectly AMPARs), a prediction is that
tCaMKII should promote the diffusional trapping of Stargazin
itself. To test this hypothesis, we coexpressed tCaMKII and
Stargazin tagged extracellularly with HA (HA-Stargazin), and
tracked the surface mobility of HA-Stargazin using QD-HA. We
found that tCaMKII caused a robust immobilization of HA-
Stargazin, but not of HA-Stargazin S9A, confirming the critical
role of CaMKII phosphorylation in the diffusional trapping of
Stargazin (Figure 5E).
Functional Implication of CaMKII-Mediated
Immobilization of AMPARs
Does CaMKII-mediated immobilization of AMPARs have a func-
tional impact on synaptic transmission? We have previously
shown that AMPAR lateral mobility ensures high-frequency
synaptic transmission (<50 ms pulse interval) by allowing the
rapid exchange of desensitized receptors with neighboring func-
tional ones (Heine et al., 2008). We showed that manipulations
that increased AMPAR immobilization, such as antibody-
mediated AMPAR cross-linking or tetanic stimulation, disrupt
this dynamic exchange and increase paired-pulse depression
(PPD). Conversely, the removal of the extracellular matrix, a
manipulation that increases mobility of AMPARs, results in
a decreased PPD (Frischknecht et al., 2009). Based on these
observations, we hypothesized that CaMKII could accentuate
PPD by restricting the exchange of desensitized AMPARs. In
order to test this hypothesis, we performed whole-cell record-
ings from pairs of connected cultured hippocampal neurons.
We applied a pair of depolarizing pulses at the presynaptic
neuron (50ms interval) and recorded EPCSs from a postsynaptic
neuron overexpressing WT or constitutively active CaMKII (Fig-
ure 6A). As shown in Figure 6B, active CaMKII strongly increased
PPD. To determine whether this effect was due to the inability of
desensitized AMPARs to escape and be replaced by functional
receptors, we repeated the experiment in the presence of
the desensitization blocker cyclothiazide (CTZ) (Trussell et al.,
1993; Yamada and Tang, 1993). CTZ completely rescued the
effect of tCaMKII on PPD by unmasking the population of immo-
bilized/desensitized AMPARs. CTZ had no effect on a pair of
untransfected neurons (Figure 6E). To ascertain that the effect
of CaMKII was due to AMPAR immobilization through Stargazin
phosphorylation, we coexpressed CaMKII T286D with Stargazin
S9A, a mutant shown above to prevent the effects of CaMKII on
AMPARmobility. Stargazin S9A completely blocked the effect of
CaMKII on PPD (Figures 6F and 6G). To verify that the rescue
was due to the phosphomutations and not to other regions of
Stargazin known to alter the intrinsic desensitization properties
of AMPARs (Tomita et al., 2005a), we examined whether WT
Stargazin could also block the effect of CaMKII T286D. In the
presence of coexpressed WT Stargazin, CaMKII T286D could
still strongly increase PPD (Figure 6G). Taken together, these246 Neuron 67, 239–252, July 29, 2010 ª2010 Elsevier Inc.results indicate that immobilization of AMPARs mediated by
active CaMKII has a strong impact on rapid synaptic transmis-
sion by disrupting the normal diffusional exchange of desensi-
tized receptors.
DISCUSSION
Our study reveals a function of CaMKII as a regulator of AMPAR
diffusional trapping at the synaptic surface and short-term
synaptic plasticity. As shown in the model (Figure 7), we uncov-
ered the molecular mechanisms underlying the Ca2+-dependent
AMPAR trapping at synapses which involves the postsynaptic
translocation of CaMKII and the direct phosphorylation of the
AMPAR auxiliary subunit Stargazin.
Role of CaMKII in the Synaptic Recruitment of AMPARs
Numerous studies have found a critical role for CaMKII in the
activity-dependent recruitment of AMPARs observed during
synaptic development and plasticity (Asrican et al., 2007; Correia
et al., 2008; Hayashi et al., 2000; Lee et al., 2009; Lisman
et al., 2002; Merrill et al., 2005; Pettit et al., 1994; Rongo and
Kaplan, 1999; Sanhueza et al., 2007). It has been suggested
that CaMKII functions by inducing either (1) the exocytosis of
AMPAR-containing vesicles or (2) the retention of receptors in
the postsynaptic density (Lisman et al., 2002). On the one
hand, CaMKII has been shown to mediate a form of dendritic
exocytosis (Maletic-Savatic et al., 1998), and recent studies
have shown that a target for CaMKII, Myosin V (Costa et al.,
1999; Karcher et al., 2001), plays an important role in the
NMDAR-dependent exocytosis of AMPARs (Correia et al.,
2008;Wang et al., 2008). On the other hand, CaMKII might recruit
AMPARs by organizing new anchoring sites for them at the
synapse (Lisman et al., 2002; Lisman and Zhabotinsky, 2001).
In fact, a number of CaMKII substrates and interacting proteins
in the PSD, including Stargazin, PSD95 and actin have been
shown to regulate the lateral mobility of AMPARs at synapses
(Bats et al., 2007).
We now propose that activity-dependent synaptic recruit-
ment of AMPARs involves both modes of operation in a two
step process involving AMPAR exocytosis and synaptic AMPAR
trapping as a result of CaMKII postsynaptic translocation and
Stargazin phosphorylation. First, we and others have recently
showed that NMDAR stimulation simultaneously triggers
AMPAR exocytosis and immobilization of AMPARs (Makino
and Malinow, 2009; Petrini et al., 2009). Second, a number
of studies indicate that the activity-dependent insertion of
AMPARs might occur at perisynaptic sites (Lin et al., 2009; Pas-
safaro et al., 2001; Yang et al., 2008; Yudowski et al., 2007).
Together with our new data, this strongly suggests that newly
inserted AMPARs at extrasynaptic sites, which are highly
diffusing in the membrane (Petrini et al., 2009), are retained
via a CaMKII-dependent mechanism into active synaptic areas.
The requirement of an NMDAR-dependent diffusional trap is
consistent with reports showing that promoting the exocytosis
of AMPARs in a NMDAR-independent manner (which probably
does not result in CaMKII activation) are not paralleled by
increases in synaptic transmission (Oh et al., 2006; Schnell
et al., 2002).
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Figure 6. CaMKII Modulation of Paired-Pulse Depression of EPSCs in Monosynaptically Connected Cultured Hippocampal Neurons
(A) Schematic representation of dual patch-clamp configuration. A pair of depolarizing pulses was applied to the presynaptic neuron (50 ms interval) and EPCSs
recorded from a postsynaptic neuron overexpressing active CaMKII.
(B) Representative EPSC traces evoked in untransfected andCaMKII T286D overexpressing neurons. Vertical and horizontal scales are 50 pA and 25ms, respec-
tively.
(C) Mean (±SEM) paired-pulse (second-to-first EPSC) ratios from data as in (B). Control, n = 18; CaMKII T286D, n = 5; tCaMKII, n = 9. p < 0.01, one-tailed Mann-
Whitney U test.
(D) Representative EPSC traces evoked in untransfected or tCaMKII (±100 mM cyclothiazide, CTZ). Vertical and horizontal scales are 50 pA and 25 ms,
respectively.
(E)Mean (±SEM) paired-pulse (second-to-first EPSC) ratios from untransfected cells and neurons transfectedwith tCaMKII (same as in (C) either in the absence or
presence of 100 mM cyclothiazide (CTZ) (**p < 0.01, one-tail).
(F) Representative EPSC traces evoked in neurons coexpressing CaMKII T286D either with WT Stargazin (STG) or Stargazin Ser9Ala (STG/S9A). Vertical and
horizontal scales are 50 pA and 25 ms, respectively.
(G) Mean (±SEM) paired-pulse (second-to-first EPSC) ratios from data as in (F). STG, n = 4; CaMKII T286D + STG, n = 5; STG/S9A, n = 5. p < 0.05, one-tailed
Mann-Whitney U test.
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Stargazin-Mediated AMPAR Immobilization by CaMKIIThe Enzymatic Activity of CaMKII Is Critical
for AMPAR Trapping
A ‘‘structural’’ model has been proposed in which CaMKII stabi-
lizes AMPARs into the synaptic area by functioning as a scaf-
folding protein (Lisman and Zhabotinsky, 2001). While CaMKII
does not bind directly to AMPARs (Kennedy, 2000; Lisman
et al., 2002), it might bridge postsynaptic elements such as
NMDAR, SAP97, 4.1N, and the actin cytoskeleton to ultimatelystabilize synaptic AMPARs. Since CaMKII is a dodecameric
and self-associating enzyme, it can potentially bind several
components simultaneously and provide additional anchoring
sites for AMPARs (Hudmon et al., 2005; Robison et al., 2005;
Rosenberg et al., 2005). A hallmark of this hypothesis is that
CaMKII organizes new anchoring sites exclusively through
protein-protein interactions independent of its kinase activity.
On the contrary, our findings establish that the enzymatic activityNeuron 67, 239–252, July 29, 2010 ª2010 Elsevier Inc. 247
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Figure 7. Model of NMDAReceptor-Dependent Trapping of Laterally
Diffusing AMPARs
At basal state, AMPARs are highly mobile at the neuronal surface, rapidly
exchanging between extrasynaptic and synaptic sites, while CaMKII is not
enriched in the PSD. Upon NMDAR activation, Ca2+/CaM activates CaMKII
and induces its postsynaptic translocation. In the PSD, CaMKII phosphory-
lates the AMPAR auxiliary protein Stargazin, facilitating its binding to PSD95
and synaptic retention, thereby indirectly stabilizing AMPARs at synapses.
At the functional level, the synaptic immobilization of AMPARs accentuates
paired-pulse depression by preventing the exchange between desensitized
and naive receptors.
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Stargazin-Mediated AMPAR Immobilization by CaMKIIof CaMKII is essential for trapping AMPARs at synapses. First,
translocation of a mutated form of CaMKII lacking enzymatic
activity was unable to trap AMPARs. Second, CaMKII phosphor-
ylation of Stargazin is critical for the diffusional trapping of both
AMPARs and Stargazin. Third, the fact that the monomeric,
constitutively active tCaMKII was able to promote the diffusional
trapping of AMPARs, even though it lacks important protein-
protein interaction domains, suggests that the kinase activity,
rather than its structure, is the primary mechanism underlying
CaMKII-dependent retention of AMPARs at synapses. This
hypothesis is further reinforced by recent data showing that
kinase-dead CaMKII knockin mice exhibit profound deficit in
LTP and learning (Yamagata et al., 2009).
Role of Stargazin in the CaMKII-Mediated
AMPAR Trapping
A paramount finding of this study is the critical role of Stargazin
in mediating the CaMKII-dependent stabilization of AMPARs
at synapses. Although it was originally proposed that the
interaction between AMPARs and the scaffold protein SAP97
was essential for AMPAR stabilization, our data indicate that
AMPARs are indirectly stabilized through the interaction
between Stargazin and PDZ-domain containing proteins such
as PSD95 (Bats et al., 2007; Chen et al., 2000). We found that
recombinant GluA1 DC (lacking the SAP97-binding site) was still
immobilized by CaMKII. In contrast, CaMKII was unable to
immobilize AMPARswhen coexpressed with StargazinDC (lack-
ing the PSD95-binding site).
An intriguing finding of our study is that active CaMKII
promotes the immobilization of both synaptic and extrasynaptic248 Neuron 67, 239–252, July 29, 2010 ª2010 Elsevier Inc.AMPARs. Although still unclear, we believe that extrasynaptic
immobilization is a consequence of the overexpression of active
CaMKII that is not specifically targeted to synapses. Since
recombinant CaMKII is also distributed extrasynaptically, it
could potentially promote the immobilization of AMPAR/Starga-
zin by binding to extrasynaptic PSD95 (Figure S4) (Aoki et al.,
2001). However, when CaMKII is targeted exclusively to
synapses (during NMDAR activation and CaMKII synaptic trans-
location), we observed AMPAR immobilization exclusively at
synaptic sites.
The exact mechanism by which Stargazin phosphorylation
decreases the mobility of AMPARs remains to be determined.
It is particularly puzzling that the CaMKII phosphorylation sites
on Stargazin are remote from its C terminus responsible for
interaction with PSD95 (Tomita et al., 2005b). It is possible that
phosphorylation triggers a conformational change in Stargazin
that increases either the binding affinity or the accessibility to
PSD95. The change in charge associated with Stargazin phos-
phorylation might for example decrease its electrostatic interac-
tion with the inner leaflet of the plasma membrane, and thus
facilitate interaction of the extreme C terminus with PSD95 as
previously proposed (Tomita et al., 2005b). Interestingly, it is
possible that the number of phosphorylated serines (from one
to nine) could act cooperatively to provide an incremental
binding to PSD95 in a rheostat-like fashion. In fact, although
Stargazin is phosphorylated at various degrees in neuronal
extracts, only highly phosphorylated Stargazin exist at the PSD
(Tomita et al., 2005b; Tsui and Malenka, 2006).
An intriguing finding of our study is the apparent GluA1
subunit-specific effect of CaMKII. Although CaMKII triggers the
immobilization of both GluA1 and GluA2 containing endogenous
AMPARs, it immobilizes recombinant GluA1 but not GluA2
homomeric AMPARs. Thus, it is likely that CaMKII immobilized
the GluA1/GluA2 subpopulation of endogenous AMPARs but
not the GluA2/GluA3 subpopulation. Although this finding is
consistent with the specific role of GluA1 in the activity-depen-
dent recruitment of AMPARs (Hayashi et al., 2000; Shi et al.,
2001), it is at oddwith the fact that Stargazin can bind all subunits
(Chen et al., 2000). Further studies are necessary to elucidate the
exact mechanism; it is possible that phosphorylation triggers
a conformational change on Stargazin that lead to stabilization
of the Stargazin-GluA1 complex and/or destabilization and
dissociation of the Stargazin-GluA2 complex. Along this line,
recent studies have demonstrated that the interaction between
Stargazin and AMPARs can be dynamically regulated by activity
(Morimoto-Tomita et al., 2009; Tomita et al., 2004).
Physiological Consequences of AMPAR
Synaptic Trapping
Although numerous studies have demonstrated a critical role
of CaMKII in the synaptic recruitment of AMPARs during LTP,
the underlying mechanisms remain unknown (Derkach et al.,
2007; Hayashi et al., 2000; Lisman et al., 2002). Our findings
suggest that during LTP, CaMKII recruits AMPARs simply by
trapping them as they diffuse through the synaptic area, whether
they were pre-existing or newly inserted on the extrasynaptic
membrane. Thismechanism is consistent with numerous studies
stressing the essential roles of CaMKII, Stargazin, and PSD95 in
Neuron
Stargazin-Mediated AMPAR Immobilization by CaMKIIthe induction of LTP (Ehrlich and Malinow, 2004; Lisman et al.,
2002; Rouach et al., 2005; Stein et al., 2003; Tomita et al.,
2005b). It remains to be determined whether the pool of laterally
diffusing AMPARs does in fact provide the additional receptors
in synapses that have undergone LTP. If so, this newly uncov-
ered function of CaMKII in trapping AMPARs diffusing on the
neuronal membrane might account for the critical role of that
enzyme in LTP. Consistent with this hypothesis, we found that
a ‘‘chemical’’ LTP protocol triggered both AMPAR immobiliza-
tion and accumulation at synapses in a CaMKII-dependent
manner.
It is unlikely that the CaMKII-mediated immobilization of
AMPARs corresponds to a universal mechanism for LTP. For
instance, LTP at the dentate gyrus is independent of CaMKII
activity (Wu et al., 2006). Also, CaMKII activity is not necessary
for LTP early in development at the CA1 region (Yasuda
et al., 2003). Further studies will be necessary to determine
whether other kinases known to be important for LTP induction,
such as PKA, PI3-K, PKC, and MAPK, also trigger AMPAR
immobilization.
Our experiments reveal a function of CaMKII as a depressor of
high-frequency synaptic transmission, in addition to its tradi-
tional role in the potentiation of low-frequency synaptic transmis-
sion or LTP (test pulses at 20 Hz versus 0.05 Hz, respectively).
Since the lateral mobility of AMPARs ensures high-frequency
synaptic transmission (Heine et al., 2008) by allowing the rapid
exchange between synaptic desensitized receptor with extrasy-
naptic naive AMPARs, it is likely that CaMKII-induced immobili-
zation of AMPARs in the synapse prevents this dynamic
exchange. As with cross-linking-induced AMPAR immobilization
(Heine et al., 2008), CaMKII-induced immobilization accentuated
PPD (50 ms pulse interval).
Our findings thus raise the possibility that during LTP, CaMKII
activation triggers both classical LTP and PPD. It is interesting to
note that LTP is frequently accompanied by a decrease in
paired-pulse facilitation (PPF) (Christie and Abraham, 1994;
Markram and Tsodyks, 1996; Schulz et al., 1995). While changes
in PPF have traditionally been ascribed to presynaptic mecha-
nisms, it will be interesting to determine whether postsynaptic
CaMKII contributes to this effect. Studies by Wang and Kelly
have in fact shown that postsynaptic injection of CaMKII inhibi-
tors blocked both LTP and the decrease in PPF (Wang and Kelly,
1996, 1997). Although our studies strongly support a role of
aCaMKII in the regulation of PPF, our findings are at odds with
studies carried out in the aCaMKII knockout animal. Rather
than an increased in PPF (as expected from reduced CaMKII
activity and increased AMPAR mobility), the aCaMKII knockout
presented a diminished PPF (Silva et al., 1992). The reasons
for this difference are unclear, but the fact that presynaptic
CaMKII, which is known to regulate vesicle release (Chapman
et al., 1995), is absent in aCaMKII/ mice, makes it difficult to
compare these findings. Indeed our results on CaMKII regulation
of short-term plasticity were limited to the postsynaptic side.
Future work is needed to dissect the differential roles of pre-
and postsynaptic CaMKII in short-term plasticity.
What is the physiological role of this seemingly ‘‘paradoxical’’
depression effect on high-frequency synaptic transmission?
It may serve a homeostatic role to avoid a run up in synaptictransmission by preventing the potentiation of already potenti-
ated synapses. Thus, high-frequency trains of synaptic transmis-
sion (50–100 Hz) should induce LTP in naive synapses by
providing the depolarization necessary to activate NMDARs
and trigger the CaMKII-dependent recruitment of additional
AMPARs. However, an eventual depression of high-frequency
synaptic transmission in ‘‘potentiated’’ synapses might set
a ceiling on the ability to activate NMDARs and further induce
potentiation.
It has indeed remained elusive how the potentiation of
synapses can reach saturation; a homeostatic mechanism
such as the one described here provides an appealing comple-
ment to CaMKII function in LTP and thus suggests that the
enzyme has a dual role in tuning the strength of synaptic trans-
mission: (1) increasing synaptic strength by retaining more
AMPARs in the synapse, while (2) capping the strength of trans-
mission by slowing exchange of desensitized AMPARs.
EXPERIMENTAL PROCEDURES
Primary Neuronal Cultures, Transfection, and Drug Treatments
Cultures of Sprague-Dawley rat hippocampal neurons, prepared by two
different protocols, were used in this study: (1) hippocampal cells from E18
rats were plated at a density of 75 cells/mm2 on poly-lysine-coated glass
coverslips and maintained essentially as described (Bats et al., 2007); (2)
hippocampal cells from P0 rats were plated at a density of 75 cells/mm2 on
poly-lysine-coated aclar coverslips and maintained essentially as described
in Hudmon et al. (2005). Except for shRNA experiments, neurons (10–12 DIV)
were transfected using Effectene as described (Bats et al., 2007) or Lipofect-
amine 2000 as described (Hudmon et al., 2005) and imaged within 16–48 hr
after transfection. For shRNA experiments, neurons were transfected at 8
DIV and kept for 4 days before live imaging or fixation for immunocytochem-
istry. For the measurements of aCaMKII::GFP postsynaptic translocation,
neurons were preincubated with the NMDAR blocker AP-5 (50 mM) after trans-
fection to prevent spontaneous translocation of the kinase (Bayer et al., 2006).
The CN21 (YGRKKRRQRRRKRPPKLGQIGRSKRVVIEDDR) and scramble
(YGRKKRRQRRRVKEPRIDGKPVRLRGQKSDRI) peptides were synthesized
with a TAT sequence by 21st Century Biochemicals. KN92 and KN93 were
purchased from Calbiochem. shRNA against aCaMKII was kindly provided
by S. Lee (Okamoto et al., 2007) with the following target sequence: 50-CCAC
TACCTTATCTTCGAT-30. For rescue experiments, we made the following
silent mutations on the aCaMKII::GFP plasmid: 50-TCATTATCTCATATTT
GAC-30. Control shRNA was directed against luciferase.
Antibodies
Weused the polyclonal antibodies against theN-terminal epitope of theGluA1-
subunit (Mammen et al., 1997; Richmond et al., 1996) and Shank-2 (Boeckers
et al., 1999). Commercial monoclonal antibodies were used against GluA2
(Chemicon MAB387), HA epitope (3F10, Roche), GFP (Invitrogen), aCaMKII
(Cba2 Zymed), bCaMKII (Cbb1 Zymed), and PSD95 (K28/43 NeuroMab).
AMPA Receptor Labeling and Synaptic Live Staining
Quantum dots (QDs) 655 Goat F(ab’)2 anti-rabbit IgG conjugate (H+L) highly
crossadsorbed were bought from Invitrogen Corporation. GluA1, GluA1-HA,
and GluA1::SEP were immunolabeled by using QD precoated with the anti-
GluA1, anti-HA, or anti-GFP antibodies, respectively. QDs (0.1 mM) were incu-
bated with 1 mg AB in 10 ml PBS for 30 min. Unspecific binding was blocked
by adding casein to the precoated QDs 15min before use. Neurons were incu-
bated 10 min at 37C in culture medium with precoated QDs (final dilution
0.1 nM). This incubation was followed by four washing steps, 30 s each. All
incubations and washes were performed in conditioned MEMmediumwithout
phenol red andwith addition of HEPES buffer (10mM). GluA2 labelingwas per-
formed in two steps; first GluA2 antibody (1/200) was incubated for 10 min
on the neurons. After three washing steps, QD655 (0.1–0.5 nM) preblockedNeuron 67, 239–252, July 29, 2010 ª2010 Elsevier Inc. 249
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50–100 nM Mitotracker Green FM or Mitotracker deep Red (Invitrogen) (2 min
incubation); (2) transfection with Homer1C::GFP or Homer1C::DsRed. All incu-
bations and washes were performed in high Mg2+-containing extracellular
solution at 37C.
Single-Molecule Optical Microscopy
Cells were imaged at 35C–37C in an open perfusion (0.2–0.5 ml/min)
chamber (Warner Instruments) mounted onto an inverted microscope equip-
ped with a 603 objective (NA = 1.35) or 1003 objective (NA = 1.3). QDs, Home-
r1C::DsRed and aCaMKII::GFP signals were detected by using a mercury
lamp (For QDs: excitation filter 560RDF55 or 460BP40 and emission filters
655WB20 or 655WB40). Fluorescent images from QDs were obtained with
an integration time of 50 ms with up to 1200 consecutive frames. Signals
were recorded with a back-illuminated thinned CCD97 camera (Photometrics
Cascade 512B, Roper Scientific). QD-labeledGluAs were imaged on randomly
selected dendritic regions over up to 30 min total experimental time. An acqui-
sition of the synaptic labeling before and after QD recording as well as QDs
fixed on the coverslip allowed us to compensatemechanical drifts of the stage,
which would have lead to a false interpretation of receptor location.
Receptor Tracking and Analysis
The tracking of single QDs was performed with homemade software based on
Matlab (Mathworks Inc., Natick, USA). Single QDs were identified by their
blinking fluorescent emission and their diffraction limited signals. Owning to
the random blinking events of the QDs, the trajectory of a QD tagged receptor
could not be tracked continuously. Subtrajectories of the same receptor
were reconnected when the positions before and after the dark period
were compatible with borders set for maximal position changes between
consecutive frames and blinking rates. The values were determined empiri-
cally: 2–3 pixels (0.32–0.48 mm) for maximal position change between two
frames and maximal dark periods of 25 frames (1.25 s). MSD curves were
calculated for reconnected trajectories of at least 75 frames. The QDs were
considered synaptic if colocalized with Mitotracker puncta or Homer dendritic
clusters for at least five frames. Diffusion coefficients were calculated by
a linear fit of the first 4–8 points of the mean square displacement (MSD) plots
versus time depending on the length of the trajectory within a certain compart-
ment. The resolution limit for diffusion was 0.0075 mm2/s as determined by
Groc et al. (2004). Despite a higher precision of QD tracked trajectories, we
used this value to compare diffusion values and immobile fractions with
previous data obtained by using single molecule tracking (Groc et al., 2004;
Tardin et al., 2003). The resolution precision was 40 nm.
Statistics
Statistical values are given as mean ± SEM or medians ± 25%/75% interval,
if not stated otherwise. Statistical significances were performed by using
GraphPadPrism software orMatlab Statistical Toolbox. Non-Gaussian distrib-
uted data sets were tested byMann-Whitney U test or Wilcoxon test for paired
observations. Indications of significance correspond to p values < 0.05 (*),
p < 0.005 (**), and p < 0.0005 (***).
Electrophysiology
The extracellular recording solution contained in mM concentration: 145 NaCl,
2.5 KCl, 2 MgCl2, 2 CaCl2, 10 HEPES, and 10 D-Glucose, pH 7.4. In order to
block GABA-A-receptors, 50 mM Picrotoxin was added to solution. The bath
temperature was kept at 33C–35C. Patch-clamp microelectrodes (4–6 MU
resistance) were pulled from borosilicate capillaries on a P-97 model puller
(Sutter Instruments Inc. (http://www.sutter.com) Recordings in voltage- and
current-clamp mode were performed with an EPC 10 double patch-clamp
amplifier (HEKA Elektronik GmbH, Lambrecht, Germany). Data were sampled
at 20 kHz and low-pass filtered at 2.9 kHz, using PatchMaster v 2.0 software
(HEKA Elektronik GmbH). Data analysis was performed with Matlab (The
MathWorks, Inc., http://www.mathworks.com). Whole-cell patch-clamps
were obtained on pairs of cells located within the same microscope field
(20–40 mm apart). To test for monosynaptic transmission, one cell was stim-
ulated in current-clampmode, by injecting a 1ms current pulse, while the other
was recorded in voltage-clampmode (70mV holding potential). Neuron pairs250 Neuron 67, 239–252, July 29, 2010 ª2010 Elsevier Inc.for which the latency between the peak of the presynaptic action potential and
the peak of the evoked excitatory postsynaptic currents (eEPSCs) was smaller
than 4 ms were retained as monosynaptically coupled (Medina et al., 1999).
The pairs were rejected when either the presynaptic neuron resting membrane
potential exceeded 55 mV or when the series resistance in both cells was
above 30 MU.
Extracellular Field Stimulation
Restricted fields of neurons (1–1.5mmbetween electrodes) were stimulated at
50 Hz. We used thin platinum wires isolated down to the tip and held within
a theta-glass electrode. In total we applied 900 stimuli for each frequency in
a regular pattern (1 s stimulus followed by 1 s pause). The length of a single
stimulus was 1 ms and the stimulus current was varied between 2 and
5 mA. The stimulation electrode was connected to an isolation unit triggered
by the patch amplifier.SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
six figures, and a movie and can be found with this article online at doi:
10.1016/j.neuron.2010.06.007.
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